IMUGENE LTD

Imugene Limited expands share structure with ASX listing of extra shares, boosting liquidity, investor base, and support for its cancer vaccine innovations.

Imugene Ltd, a biotech company developing vaccines for gastric and breast cancer, faces financial volatility and market skepticism, raising questions about its ability to navigate the competitive biotechnology sector.